Skip to main content

Table 1 Patient characteristics

From: Tumor-related gene expression levels in pulmonary pleomorphic carcinoma

Case Age/Sex Stage Chemotherapy Relapse   Status
1 70/M T2bN1M0 (+) Distant 16 mo Dead
AMR
2 75/M T2bN1M0 (−) (−) 39 mo Alive
3 57/M T2aN0M0 (+) Distant 42 mo Alive
AMR, CBDCA + PTX
4 77/M T2bN0M0 (−) Distant 9 mo Dead
5 68/M T2aN0M0 (+) (−) 57 mo Alive
DTX + TS1
6 80/M T3N0M0 (−) Distant 57 mo Alive
7 54/M T3N0M0 (−) Locala 2 mo Dead
8 47/M T2bN0M0 (+) Distant 12 mo Dead
TS1, CDDP + VNR, CBDCA + PTX
9 48/F T2aN1M1 (+) Distant 14 mo Dead
CBDCA + DTX
10 73/M T2bN0M0 (−) (−)b 2 mo Dead
  1. Each stage is presented based on the 7th UICC TNM classification
  2. mo months, AMR amrubicin, CBDCA carboplatin, PTX paclitaxel, TS1 tegafur gimeracil oteracil, DTX docetaxel, VNR vinorelbine
  3. aincomplete resection
  4. boperative death due to cerebral infarction